X

Today's Newsletter

Submitted by admin on Fri, 09/24/2021 - 11:51

source list reference

rgb(171, 222, 222)
#7d60d9
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
#352625
#4d4537
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
#d2093c
#8e3f1c
rgb(242, 0, 137)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
#c61417
rgb(156, 242, 7)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(80, 147, 199)
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
#a60538
rgb(2, 230, 230)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834

Today's Newsletter

Today's Newsletter

Submitted by sholland@hmpgl… on Fri, 10/22/2021 - 14:55

Today's Newsletter

10-25-2021

Quickly catch up on the top oncology news stories of the day.

`
Extended Letrozole Prolonged Survival in Postmenopausal Patients With Breast Cancer

When compared with the standard 2-3 years of letrozole, 5 years of letrozole treatment improved both disease-free survival and overall survival.

Cancer Therapy Advisor
10/18/2021
``
``
A Multi-Modal, Physician-Centered Intervention to Improve Guideline-Concordant Prostate Cancer Imaging

Research describes and analyzes the implementation of the PCIS intervention to determine the effect of a physician-focused behavioral intervention on VHA prostate cancer imaging use. 

Trials
10/18/2021
Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia

Somatic mutations in AML patients were found using The Cancer Genome Atlas dataset and BeatAML dataset and then researchers identified the common mutant genes in the two cohorts. 

Frontiers in Immunology
10/21/2021
Prognostic Value of Immune-Related lncRNA Pairs in Patients With Bladder Cancer

Research establishes a novel model to predict the efficacy of immunotherapy regardless of expression.

World Journal of Surgical Oncology
10/18/2021
Replication Catastrophe is Responsible for Intrinsic PAR Glycohydrolase Inhibitor-Sensitivity in Patient-Derived Ovarian Cancer Models

Scientists explore the use of a transcript-based biomarker, and provide insight into the design of future clinical trials of PARGi in patients with ovarian cancer.

Journal of Experimental & Clinical Cancer Research
10/16/2021
Hsp90 Up-Regulates PD-L1 to Promote HPV-Positive Cervical Cancer via HER2/PI3K/AKT Pathway

The therapeutic effect of heat shock protein 90 knockdown on HPV16+ cervical cancer progression and the underlying mechanism is investigated.

Molecular Medicine
10/19/2021